1. Home
  2. CYTK vs CUBE Comparison

CYTK vs CUBE Comparison

Compare CYTK & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo CubeSmart

CUBE

CubeSmart

HOLD

Current Price

$37.28

Market Cap

8.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
CUBE
Founded
1997
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.6B
IPO Year
2004
2004

Fundamental Metrics

Financial Performance
Metric
CYTK
CUBE
Price
$63.34
$37.28
Analyst Decision
Strong Buy
Buy
Analyst Count
16
14
Target Price
$84.81
$44.42
AVG Volume (30 Days)
1.8M
2.3M
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
5.65%
EPS Growth
N/A
N/A
EPS
N/A
1.55
Revenue
$87,211,000.00
$1,110,530,000.00
Revenue This Year
$341.94
$2.65
Revenue Next Year
$75.44
$2.55
P/E Ratio
N/A
$24.22
Revenue Growth
2609.26
4.09
52 Week Low
$29.31
$34.24
52 Week High
$70.98
$44.13

Technical Indicators

Market Signals
Indicator
CYTK
CUBE
Relative Strength Index (RSI) 49.19 47.97
Support Level $62.13 $36.91
Resistance Level $65.88 $37.79
Average True Range (ATR) 2.59 0.76
MACD 0.07 -0.15
Stochastic Oscillator 54.84 12.57

Price Performance

Historical Comparison
CYTK
CUBE

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: